{"organizations": [], "uuid": "7c222b542d755de3c3daa1b271c6f30cd449e9f2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180404.html", "section_title": "Archive News &amp; Video for Wednesday, 04 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-humanwell-healthcare-group-unit-re/brief-humanwell-healthcare-group-unit-receives-fda-approval-idUSL4N1RH351", "country": "US", "domain_rank": 408, "title": "BRIEF-Humanwell Healthcare Group unit receives FDA approval", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-04T15:45:00.000+03:00", "replies_count": 0, "uuid": "7c222b542d755de3c3daa1b271c6f30cd449e9f2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-humanwell-healthcare-group-unit-re/brief-humanwell-healthcare-group-unit-receives-fda-approval-idUSL4N1RH351", "ord_in_thread": 0, "title": "BRIEF-Humanwell Healthcare Group unit receives FDA approval", "locations": [], "entities": {"persons": [], "locations": [{"name": "united states", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "epic pharma", "sentiment": "negative"}, {"name": "brief-humanwell healthcare group", "sentiment": "negative"}, {"name": "reuters) - humanwell healthcare group co ltd * says co", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "u.s food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 4(Reuters) - Humanwell Healthcare Group Co Ltd\n* Says coâ€™s wholly owned unit Epic Pharma, LLC received FDA approval for its Hydrocodone Bitartrate and Acetaminophen Tablet (medicine) from U.S Food and Drug Administration\n* Says unit will be able to sell this medicine in the United States after receiving the FDA approval\nSource text in Chinese: goo.gl/B9mfHb\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "https://goo.gl/B9mfHb"], "published": "2018-04-04T15:45:00.000+03:00", "crawled": "2018-04-05T17:10:07.000+03:00", "highlightTitle": ""}